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Balloon mitral valvuloplastyAbstract Background: The predisposition to atrial ﬁbrillation (AF) in mitral stenosis (MS) has
been demonstrated with several electrocardiographic (increased P-wave dispersion) and echocardio-
graphic parameters (atrial electromechanical delay). After percutaneous mitral balloon valvulo-
plasty (PMBV), the improvement in echocardiographic parameters related to AF risk is
unknown. We aimed to assess the interatrial electromechanical coupling by Tissue Doppler
Imaging (TDI) echocardiography in MS before and after PBMV.
Patients and methods: This study included 45 patients with moderate to severe MS who underwent
successful PMBV without complication at our clinic and 20 healthy volunteers as a control group.
We compared the two groups in regard to clinical, electrocardiographic and echocardiographic fea-
tures. The patients with MS were also evaluated one week after PMBV. Interatrial electromechan-
ical delay (EMD) was measured by TDI before and after PMBV and we compared the results.
76 A. Saad et al.Results: The interatrial EMD (56.4 ± 15.8 vs. 34.6 ± 7.2 ms, p< 0.001) was higher in patients
with MS as compared to healthy individuals. The maximum P-wave duration (P-max) and P-
wave dispersion (PWD) showed signiﬁcant positive correlation with the interatrial EMD
(r= 0.37, p< 0.05 and r= 0.41, p< 0.05 respectively). There was a highly signiﬁcant decrease
in the interatrial EMD (56.4 ± 15.8 vs. 38.3 ± 10.4 ms, p< 0.001) one week after PBMV.
Conclusion: The current study showed signiﬁcant increase in the interatrial EMD in patients with
moderate to severe MS. These changes improved signiﬁcantly after PMBV.
ª 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Cardiology.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).1. Introduction
Atrial electromechanical abnormalities have been reported to
promote atrial ﬁbrillation (AF).1,2 O¨zer et al.3 used Tissue
Doppler Imaging (TDI) and surface ECG to show interatrial
electromechanical delay (EMD) in patients with mitral stenosis
(MS). Percutaneous balloon mitral valvuloplasty (PBMV) has
become the procedure of choice for isolated, uncomplicated
MS with favorable morphology.4 The initial objectives of the
procedure are to increase the cross-sectional valve area and
simultaneously to reduce the trans-mitral pressure gradient,
left atrial pressure, and mean pulmonary artery pressure.5,6
Atrial electromechanical coupling time [the time interval from
the onset of P wave on surface ECG to the beginning of A0
wave interval with TDI (PA0)] is measured and interatrial
EMD can be calculated from PA0 values of selected regions.3
1.1. Aim of the work
We aimed to assess the interatrial electromechanical coupling
by Tissue Doppler Imaging (TDI) echocardiography in MS
before and after PBMV.
2. Patients and methods
The study conducted in Cardiology Department, Faculty of
Medicine, Zagazig University from August 2010 to March
2014 included 65 human individuals: 17 males, 48 females
who were divided into 2 groups: Group I (Rheumatic Mitral
Stenosis group): includes 45 patients; (33 females and 12 males,
aged 30.1 ± 8.99 years, with a mean mitral valve area (MVA)
of 0.99 ± 0.15 cm2) who underwent successful PBMV without
complications and Group II (Control group): includes 20
healthy volunteers (15 females and 5 males, aged
30.6 ± 7.8 years). The Group II did not have any known
cardiovascular disease or cardiovascular risk factors. All
patients with MS were New York Heart Association
classP II and were eligible for PBMV. The patients with left
ventricular dysfunction, hypertension, diabetes mellitus, left
ventricular hypertrophy, coronary artery disease, signiﬁcant
pulmonary disease, or additional moderate or severe valvular
heart disease other than secondary tricuspid regurgitation were
excluded from the study. All patients were in sinus rhythm
during evaluation. The study patients underwent comprehen-
sive echocardiographic examinations one day before and one
week after PBMV. Mitral valve anatomy was scored according
to the Wilkins echo scoring system.7 After excluding thecontraindications for the procedure with transthoracic and
transesophageal echocardiography, PBMV was performed.
Also 12-lead ECGs were recorded for each study patient one
day before and one week after PBMV. The study protocol
was approved by the institutional ethics committee and all
patients gave informed consent.
2.1. Echocardiography
All echocardiographic examinations were performed with the
VIVID 9 ultrasound system (GE, Horten, Norway) using
2.5–3.5 MHz transducers. In addition to standard M-mode,
two-dimensional and Doppler measurements evaluating car-
diac chambers and the severity of MS and TDI were used.
During echocardiographic evaluation a continuous one-lead
ECG recording was provided. Data were recorded from the
average of three cardiac cycles. Left ventricle (LV)
end-diastolic, end-systolic diameters and left atrial (LA)
end-systolic diameter were measured with M-mode in the
parasternal long axis view according to American Society of
Echocardiography guidelines. MVA was measured using the
planimetry method in the parasternal short axis view. From
the apical four-chamber view, peak and mean trans-mitral gra-
dients in (mmHg) were measured by using continuous wave
Doppler echocardiography according to the modiﬁed
Bernoulli equitation. Systolic pulmonary artery pressure
(SPAP) was calculated from the peak continuous wave
Doppler signal of tricuspid regurgitation jet velocity and
adding the estimated right atrial pressure to this value. The
Sampson’s biplane modiﬁed method was used to estimate the
LA volume. The following LAVs were measured: the maximal
volume (Vmax) during left ventricular end-systole just before
mitral valve opening, the minimal volume (Vmin) just before
mitral valve closure on the simultaneously recorded ECG.8
The LA volume index was calculated by dividing the LA
volume by body surface area. LA ejection fraction (LAEF) is
deﬁned as (Vmax  Vmin)/Vmax · 100%).8–10 LA expansion
index (LAEI) is deﬁned as (Vmax  Vmin)/Vmin · 100%).8–10
TDI echocardiography was performed with transducer fre-
quencies of 3.5–4.0 MHz by adjusting the spectral pulsed
Doppler signal ﬁlters until a Nyquist limit of 15–20 cm/s was
reached and using the minimal optimal gain. The monitor
sweep speed was set at 100 mm/s. In the apical four-chamber
view the pulsed Doppler sample volume was placed on the
LV lateral mitral annulus and tricuspid annulus. The time
interval from the onset of P wave on the surface electrocardio-
gram to the beginning of the late diastolic wave, which is
referred to as PA0, was obtained from lateral mitral annulus
Figure 1 Measurement of the time interval from the onset of P wave on surface ECG to the beginning of A0 wave with tissue Doppler
echocardiography (PA0).
Table 1 The clinical, echocardiographic and electrocardiographic parameters of the studied groups.
Group I (MS) (n= 45) Group II (Control) (n= 20) P-value
Age (years) 30.1 ± 8.99 30.6 ± 7.8 0.22
Gender (n%)
Male 12 (26.7%) 5 (25%) 0.88
Female 33 (73.3%) 15 (75%)
BSA 1.72 ± 0.1 1.71 ± 0.1 0.37
Systolic BP (mmHg) 115.7 ± 8.4 114.5 ± 6.7 0.5
Diastolic BP (mmHg) 68.8 ± 6.4 71.2 ± 7.4 0.17
HR (beats/min) 79 ± 9.8 76.2 ± 6.5 0.24
LVEDD (mm) 46.1 ± 5.3 41.5 ± 4.4 0.0013
LVESD (mm) 28.8 ± 4.2 26.8 ± 3.3 0.06
IVST (mm) 9.25 ± 0.8 8.8 ± 0.9 0.06
PWT (mm) 8.95 ± 1 8.56 ± 1 0.11
EF (%) 67.2 ± 5.76 65.9 ± 3.8 0.3
LAD (mm) 47 ± 3.7 30.4 ± 3.6 <0.001
LAVmax (ml) 109.7 ± 29.8 41.7 ± 6.9 <0.001
Ind. LAVmax (ml/m
2) 63.8 ± 16.96 24.4 ± 4.5 <0.001
LAEF (%) 30.9 ± 7.7 49.3 ± 6.2 <0.001
LAEI (%) 46 ± 19.3 104.1 ± 34.9 <0.001
Lateral mitral annulus P–A0 (ms) 117.9 ± 16.7 87.9 ± 7.5 <0.001
Tricuspid annulus P–A0 (ms) 60.8 ± 10 53.3 ± 53 0.08
Interatrial EMD (ms) 56.4 ± 15.8 34.6 ± 7.2 <0.001
ECG ﬁndings
Pmax (ms) 137.4 ± 12.1 102.4 ± 6.1 <0.001
Pmin (ms) 72 ± 12.9 77.7 ± 4.1 0.056
PWD (ms) 64.4 ± 13.5 24.6 ± 4.7 <0.001
BP: blood pressure, BSA: body surface area, HR: heart rate, EF: ejection fraction, interatrial EMD: the difference between the P–A0 (lateral)
and P–A0 (tricuspid) time intervals, IVST: interventricular septum thickness, LAD: left atrial diameter, LAEF: left atrial ejection fraction,
LAEI: left atrial expansion index, LAV: left atrial volume, LVEDD: left ventricle end diastolic diameter, LVESD: left ventricle end systolic
diameter, P–A: the time interval from the initiation of the P wave on the ECG until the beginning of the late diastolic TDI signal at the lateral
border of the annulus, Pmax: maximum P-wave duration, Pmin: minimum P-wave duration, PWD: P-wave dispersion, PWT: posterior wall
thickness.
P value >0.05 = non-signiﬁcant.
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Figure 2 Pearson’s correlation between interatrial EMD and P-
max in MS group. Abbreviation: D Lateral P–A0 – Tricuspid P–A0
(ms): The difference between the P–A0 (Lateral mitral) and P–A0
(Tricuspid) time intervals.
78 A. Saad et al.(lateral PA0) and tricuspid annulus (tricuspid PA0) Fig. 1. The
difference between both lateral mitral PA0 and tricuspid PA0
was deﬁned as interatrial electromechanical delay (EMD).11
2.2. Twelve-lead ECG
Twelve-lead ECGs were recorded at a rate of 25 mm/s in a
supine position. P wave duration was measured from the onset
to the offset of P wave. The measurements were made using a
digital caliper and magnifying lens in order to improve accu-
racy. Maximum and minimum P-wave durations were deter-
mined from 12-lead ECGs. Subsequently, P-wave dispersion
(PWD) was deﬁned as the difference between maximum P-
wave and minimum P-wave durations.11
2.3. Percutaneous balloon mitral valvuloplasty
Indications for PBMV were as follows: symptomatic patients
with moderate or severe MS with favorable valve morphology
and asymptomatic patients with moderate or severe MS andTable 2 The effects of PMBV on echocardiographic and electrocar
Group I bef
MVA (cm2) 0.99 ± 0.1
Mean transmitral gradient (mmHg) 15.4 ± 3.5
SPAP (mmHg) 56.7 ± 12.
MVA pHt. (cm2) 1.05 ± 0.1
LAD (mm) 47 ± 3.7
LAVmax (ml) 109.7 ± 29.
Ind. LAVmax (ml/m
2) 63.8 ± 16.
LAEF (%) 30.9 ± 7.7
LAEI (%) 46 ± 19.
Lateral mitral annulus P–A0 (ms) 117.9 ± 16.
Tricuspid annulus P–A0 (ms) 60.8 ± 10
Interatrial EMD (ms) 56.4 ± 15.
ECG ﬁndings
Pmax (ms) 137.4 ± 12.
Pmin (ms) 72 ± 12.
PWD (ms) 64.4 ± 13.
MVA: mitral valve area, SPAP: systolic pulmonary artery pressure.
P value >0.05 = non-signiﬁcant.pulmonary hypertension (SPAPP 50 mmHg at rest or
60 mmHg with exercise) with favorable valve morphology.11
Before PBMV, all patients were evaluated by transthoracic
and trans-esophageal echocardiography in order to exclude the
contraindications of the procedure such as moderate or severe
mitral regurgitation, severe or bi-commissural calciﬁcation and
presence of LA thrombus.11
An experienced cardiologist performed all PBMV proce-
dures via a double balloon, multi-track technique in a fasting
state utilizing percutaneous trans-femoral approach.
Standard hemodynamic measurements of right and left heart
pressures were evaluated during the procedure.12
2.4. Statistical analysis
Data checked, entered and analyzed by SPSS version 20. Data
were expressed as mean ± SD for quantitative values, num-
bers and percentage for categorical variables. ANOVA (f test),
paired-t test, Chi-square (x2) and Pearson’s correlation r were
used when appropriate. We considered results statistically sig-
niﬁcant when p value 6 0.05.
3. Results
The baseline demographic, clinical, echocardiographic and
electrocardiographic parameters of Group I and Group II
are shown in Table 1. There were no signiﬁcant differences
between Group I and Group II as regards age, gender, body
surface area, blood pressure, LV end systolic diameter
(LVESD) and LV function (p> 0.05). The LA diameter, LA
volume, LA volume index and lateral mitral PA0 values were
signiﬁcantly higher in Group I (p< 0.001), but LAEF and
LAEI were highly signiﬁcant decrease in Group I (p< 0.05)
as compared with Group II. Interatrial EMD was also highly
signiﬁcant longer in Group I as compared with Group II
(p< 0.001). P-max duration and PWD were found highly sig-
niﬁcant increase in Group I as compared with Group II
(p< 0.001). However, there was no statistical differencediographic parameters.
ore PBMV Group I after PBMV P-value
5 1.88 ± 0.2 <0.001
5 5 ± 1.5 <0.001
5 35.9 ± 5.2 <0.001
6 1.89 ± 0.2 <0.001
41.5 ± 3.02 <0.001
8 86.4 ± 26.2 <0.001
96 49.9 ± 14.8 <0.001
43.4 ± 5.4 <0.001
3 78.6 ± 17.4 <0.001
7 95.9 ± 12.7 <0.001
57.2 ± 10.9 0.16
8 38.3 ± 10.4 <0.001
1 115.6 ± 13 <0.001
9 71.7 ± 12.2 0.1
5 47.4 ± 12.6 <0.001
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(P-min) (p> 0.05).
A comparison of changes in electrocardiographic and
echocardiographic parameters in Group I before and after
PMBV is shown in Table 2. All patients underwent successful
PMBV and statistically highly signiﬁcant improvement
occurred in MVA, trans-mitral mean gradient, pulmonary
artery pressure, LA diameter, both LA volume and volume
index, LAEF and LAEI. Accompanying these hemodynamic
effects of the procedure, the ECG parameters of P-max dura-
tion and PWD showed a highly signiﬁcant decrease one week
after PMBV (p< 0.001). However, the procedure had no sig-
niﬁcant effect on minimum P-wave duration (p> 0.05).
Lateral mitral PA0 values were found to be highly signiﬁcantly
decreased after PMBV (p< 0.001) but tricuspid PA0 interval
was statistically not affected by the procedure (p > 0.05). In
addition, interatrial EMD was highly signiﬁcantly improved
as compared to previous values (p< 0.001).
In correlation analysis, a signiﬁcant positive correlation was
detected between interatrial EMD and P-max duration
(r= 0.37, p< 0.05) and PWD (r= 0.41, p< 0.05) Figs. 2
and 3 respectively.
The LA diameter, LAVmax and Ind. LAVmax had a positive
association with interatrial EMD (r= 0.31, p< 0.05; r= 0.33,
p< 0.05 and r= 0.33, p< 0.05, respectively) Table 3.r = 0.41 , P<0.05
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Figure 3 Pearson’s correlation between interatrial EMD and
PWD in MS group. Abbreviation: D Lateral P–A0 – Tricuspid P–
A0 (ms): The difference between the P–A0 (Lateral mitral) and P–
A0 (Tricuspid) time intervals.
Table 3 Correlations between interatrial EMD and other
ECG and echocardiographic parameters in Group I.
R P
Pmax 0.37 0.05
PWD 0.41 0.05
LAD 0.31 <0.05
LAVmax 0.33 <0.05
Ind.LAVmax 0.33 <0.05
Ind. LAVmax: maximal left atrial volume indexed to BSA; LAD:
left atrial dimension; P-max: maximum P-wave duration; PWD:
P-wave dispersion.
P value >0.05 = non-signiﬁcant.4. Discussion
Atrial conduction disorders are frequent for patients with
mitral valve disease. The resultant electrophysiological and
electromechanical abnormalities caused by atrial conduction
abnormalities are associated with a higher risk of AF.13 Both
the hemodynamic changes that result in increased LA pressure
and volume and the ﬁbrotic process impairing atrial conduc-
tion are reported to be related to the higher risk of AF in these
patients.14
TDI is a technology that allows direct and non-invasive
measurement of myocardial velocities.15 Atrial electromechan-
ical delay is evaluated by TDI, a relatively novel noninvasive
method for assessing atrial conduction time.16
This study aimed to assess the interatrial electromechanical
coupling by TDI in mitral stenosis before and after PBMV.
We included 45 patients with MS with mean MVA
0.99 ± 0.15 cm2, who underwent PBMV with improved
MVA (1.89 ± 0.2 cm2) and 20 healthy individuals as control
group. All were examined by TTE with TDI to measure the
electromechanical coupling.
We found signiﬁcant increase in both P-max and PWD in
MS group compared to control group (p< 0.001).
Our ﬁndings are in agreement with Krishnamoorthy and
colleagues 17, who demonstrated that P-max and PWD
increased in patients with MS and attributed this to LA hyper-
tension that caused LA dilatation, ﬁbrosis, and electrical
inhomogeneity.
Concerning the echocardiographic parameters, our results
showed the signiﬁcant increase in LAD and both maximal
and minimal left atrial area in MS group compared to control
group (p< 0.001).
These ﬁndings are in agreement with the results of O¨zer
et al.3 who stated that LA size and area increase for patients
in MS group. As LA size increases, the pathway of the cardiac
impulse will also increase. Accordingly, interatrial EMD will
increase.
Krasuski et al.18 correlated the development of AF to the
severity of MS, LA pressure and also to the degree of LA
enlargement. In a dilated LA, the time interval for impulse
conduction will be longer. In addition to LA enlargement, loss
of atrial myocytes and ongoing interstitial ﬁbrosis results in
electrical remodeling characterized by inhomogeneous electri-
cal properties and abnormalities in conduction velocity.19
Our results regarding left atrial indices, showed signiﬁcant
decrease in LAEF and LAEI in MS group compared to con-
trol group (p< 0.001). These may lead to impairment of LA
reservoir function in MS patients by using both previous
indices. These indices are analogous to the LA diastolic func-
tion. The LA reservoir dysfunction, which reﬂects ‘‘diastolic’’
dysfunction of LA, is likely to occur before LA booster
dysfunction, which represents ‘‘systolic’’ dysfunction of the
LA.20 LA dysfunction may induce thrombogenesis,
intra-atrial stasis with dense spontaneous contrast in LA,
and occurrence of AF.21
We calculated LAEF and LAEI from LA volumes as these
are more predictive of future AF and other cardiovascular
events than LA dimension. These results come in agreement
with Tsang et al.22,23 who suggesting that LA volume may
be a more sensitive index of LA remodeling than LA
dimension.
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interatrial EMD in MS group compared with control group
(p< 0.001).
These ﬁndings come in agreement with the results of O¨zer
et al.3 who stated that interatrial EMD gets longer in MS
patients group compared with control healthy subjects. Also,
Demirkan et al.11 found that patients with moderate to severe
MS had longer interatrial conduction time as compared with
control subjects.
PBMV, which is the procedure of choice in the treatment of
rheumatic MS, has excellent immediate and long-term results
in patients with favorable mitral valve morphology but those
with less favorable anatomy may still have reasonably good
hemodynamic and symptomatic relief.24 Although there are
no data from comparative studies, PBMV is estimated to
reduce the incidence of AF.25
Our ﬁndings after one week from the valvuloplasty reﬂect
mitral valve afterload reduction by the highly signiﬁcant
increase in mitral valve area and LAEF, while there was highly
signiﬁcant decrease in mean and peak mitral valve gradients,
LAD and pulmonary systolic pressure (p< 0.001).
Our results are in agreement with Vieira et al.26 who stated
that the main acute impacts on the LA were a decrease in the
mitral valve afterload, as reﬂected by an increase in the mitral
valve area, a decrease in the mean and peak mitral valve gra-
dients, a decrease in pulmonary systolic pressure, and a
decrease in the LA anteroposterior diameter.
Also, these results come in agreement with Morttada et al.27
who assess the impact of successful PBMV with a signiﬁcant
increase in the mitral valve area, decrease in the pressure gra-
dient across the mitral valve and decrease in SPAP leading to a
decrease in left atrial pressure, pulmonary venous congestion
and pulmonary artery pressure.
One week after PBMV, we documented a highly signiﬁcant
improvement in all LA indices (LAAmax, LAVmax, Ind.
LAVmax and Ind. LAVmin). We documented a highly signiﬁ-
cant reduction in the Ind. LAVmax by 21.8% (p< 0.001).
These ﬁndings come in agreement with Antonini et al.28
who stated that LA reverse remodeling after PBMV, consid-
ered to have occurred when the Ind. LAVmax decreased by
>15%, as previously described for LA analysis after mitral
valve surgical repair.
Also, Adavane et al.29 found that the Ind. LAVmax reduced
immediately after PBMV by 14.2% and reduced by 23.2%
30 days after PBMV. In another study, the Ind. LAVmax
reduced by 16% at 72 h and by 21.5% 12 months after PBMV.
We found highly signiﬁcant increase in LAEF and LAEI
one week after PBMV (p< 0.001), indicating improvement
in the LA reservoir function, and these results are not agreed
with Pritchett et al.30 who stated that assessing atrial mechan-
ical function by measuring volumes is time-consuming and
depends on age, gender, and body surface area.
We documented a highly signiﬁcant decrease in P-max and
PWD (p< 0.001) one week after PBMV.
These ﬁndings are in agreement with Turhan et al.31 who
demonstrated decrease in P-max and PWD, which were
regarded as ECG signs of the susceptibility to AF in both
the short and long terms after PBMV.
One week after PBMV, regarding the interatrial EMD, there
was a highly signiﬁcant decrease in interatrial EMD using TDI
(p< 0.001).This result is in agreement with that of Demirkan et al.11
who studied the interatrial EMD before and 72 h after valvu-
loplasty, and they explained this by the immediate decline in
LA stretch (as a result of the immediate drop in LA pressure),
also in their study both LA diameter and LA volume were
decreased signiﬁcantly after PBMV.
Finally, we found that interatrial EMD signiﬁcantly corre-
lated positively with LAD and showed positive association
with LAA, and these results are in agreement with O¨zer et al.3
who showed that LA size and area are correlated positively
with interatrial EMD measured with noninvasive method for
patients with MS.
In our study, we found signiﬁcant positive correlation
between echocardiographic interatrial EMD and both electro-
cardiographic AF markers (P-max and PWD) (p< 0.05).
Our results are in agreement with O¨zer et al.3 who used this
TDI method for investigating interatrial EMD in patients with
MS, and they detected a positive correlation between intera-
trial EMD and LA size, as well as between interatrial EMD
and electrocardiographic AF markers (P-max and PWD).
5. Study limitations
In addition to the small sample size, there are some limitations
of our study. We did not have long-term follow-up data.
Therefore, the relationship between these parameters and the
development of AF is not clearly known. Moreover, our
patients were relatively young and had somewhat lower
Wilkins scores. Therefore, our results might not be applicable
to all patients with MS who have more severe disease with
higher Wilkins scores, patients of relatively advanced age or
patients who have more inﬂammatory response. Further
prospective studies should be carried out to clarify the relation-
ship between these parameters and the incidence of AF.
6. Conclusions
This study shows that interatrial EMD gets longer in patients
with moderate to severe MS compared to control subjects and
is positively correlated with PWD, which is a marker of AF for
such patients. Also, percutaneous balloon dilatation of the
mitral valve had a favorable effect on atrial conduction prop-
erties evaluated with both TDI echocardiography and ECG.
These parameters, obtained by TDI, are easily measured in
the clinical setting, and are useful in atrial function evaluation
and hence in the prediction of AF.
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